CD4 and Schwartz-Jampel syndrome: This retrospective cohort study has shown that the use of systemic corticosteroids together with IVIGs for the treatment of SJS/TENS in HIV-infected patients resulted in a 97.2% survival rate compared to the previous report, which has a mortality rate of 30.0%.4 We observed that CD4 cell counts and SCORTEN score did not impact the mortality rate in HIV-infected patients.